|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-2-2
|
|
pubmed:abstractText |
Sentinel node biopsy (SNB) is used for evaluation of axillary lymph node status of patients with breast cancer. The usefulness of SNB after neoadjuvant chemotherapy is not established. In addition, SNB after endocrine therapy has rarely been evaluated. We assessed the feasibility of dye guided SNB after neoadjuvant endocrine therapy in comparison with those of SNB after chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anthracyclines,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal,
http://linkedlifedata.com/resource/pubmed/chemical/Bridged Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Goserelin,
http://linkedlifedata.com/resource/pubmed/chemical/Nitriles,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids,
http://linkedlifedata.com/resource/pubmed/chemical/Triazoles,
http://linkedlifedata.com/resource/pubmed/chemical/anastrozole,
http://linkedlifedata.com/resource/pubmed/chemical/taxane
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0022-4790
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2004 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
85
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
77-81
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14755507-Adult,
pubmed-meshheading:14755507-Aged,
pubmed-meshheading:14755507-Aged, 80 and over,
pubmed-meshheading:14755507-Anthracyclines,
pubmed-meshheading:14755507-Antineoplastic Agents, Hormonal,
pubmed-meshheading:14755507-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14755507-Axilla,
pubmed-meshheading:14755507-Breast Neoplasms,
pubmed-meshheading:14755507-Bridged Compounds,
pubmed-meshheading:14755507-Feasibility Studies,
pubmed-meshheading:14755507-Female,
pubmed-meshheading:14755507-Goserelin,
pubmed-meshheading:14755507-Humans,
pubmed-meshheading:14755507-Lymph Nodes,
pubmed-meshheading:14755507-Middle Aged,
pubmed-meshheading:14755507-Neoadjuvant Therapy,
pubmed-meshheading:14755507-Nitriles,
pubmed-meshheading:14755507-Pilot Projects,
pubmed-meshheading:14755507-Sentinel Lymph Node Biopsy,
pubmed-meshheading:14755507-Tamoxifen,
pubmed-meshheading:14755507-Taxoids,
pubmed-meshheading:14755507-Triazoles
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Feasibility of sentinel node biopsy for breast cancer after neoadjuvant endocrine therapy: a pilot study.
|
|
pubmed:affiliation |
Department of Surgery, Kansai Rosai Hospital, 3-1-69 Inabaso, Amagasaki, Hyogo 660-8511, Japan. aiharat@kanrou.net
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
